JTB wt Allele

Known as: B PAR, PAR, BPAR 
Human JTB wild-type allele is located within 1q21 and is approximately 4 kb in length. This allele, which encodes protein JTB, is involved in jumping… (More)

Topic mentions per year

Topic mentions per year

1993-2018
05101519932018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
As part of the Spare-the-Nephron trial, we evaluated the combination mycophenolate mofetil (MMF) and sirolimus (SRL) as a… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
BACKGROUND We hypothesized that a high within-patient variability in clearance of tacrolimus and mycophenolate mofetil (MMF… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
Mycophenolate mofetil (MMF) was developed with cyclosporine as a fixed-dose immunosuppressant. More recent data indicate a… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Fixed-dose mycophenolate mofetil (MMF) reduces the incidence of acute rejection after solid organ transplantation. The… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
In a randomized, open-label, multicenter study, de novo renal transplant patients received no steroids (n = 112), steroids to day… (More)
Is this relevant?
2008
2008
Renal transplant outcomes exhibit large inter-individual variability, possibly on account of genetic variation in immune-response… (More)
Is this relevant?
2006
2006
FTY720 is a novel immunomodulator investigated in de novo renal transplantation and other therapeutic areas including multiple… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Everolimus 1.5 or 3 mg/day was compared with mycophenolate mofetil (MMF) 2 g/day in a randomized, multicenter 36-month trial in… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The introduction of mycophenolate mofetil (MMF) represented a major advance in transplant medicine, although optimal use may be… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Two prospective, randomized studies evaluated everolimus 1.5 vs. 3 mg/day with steroids and low-exposure cyclosporine (CsA) (C2… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?